Ablative Radioembolization of Renal Cell Carcinoma Trial

Clinical trial NCT06642220 · RECRUITING

Trial details

NCT number: NCT06642220
Sponsor: Derek W. Cool
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma (RCC)Radioembolization

Start date: 2025-07-09
Primary completion: 2028-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.